ArticleCell discovery2022

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs.

Dengyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.